Search filters

List of works by Ksenia Matlawska-Wasowska

CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS.

scientific article published on 4 October 2016

Characterization of the anti-CD22 targeted therapy, moxetumomab pasudotox, for B-cell precursor acute lymphoblastic leukemia

scientific article published on 27 April 2017

Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy.

scientific article

Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia.

scientific article

Drugging DNA repair to target T-ALL cells

scientific article published on 8 November 2017

Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia.

scientific article

Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia

scientific article published on 03 May 2019

Eradication of LIG4-deficient glioblastoma cells by the combination of PARP inhibitor and alkylating agent

scientific article published on 07 December 2018

Genotoxic effects of irinotecan combined with the novel platinum(II) complexes in human cancer cells.

scientific article published on 14 July 2010

High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALL

article

Integration of ruxolitinib into dose-intensified therapy targeted against a novel JAK2 F694L mutation in B-precursor acute lymphoblastic leukemia.

scientific article published on 15 November 2016

MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study

scientific article

Macrophage and NK-mediated killing of precursor-B acute lymphoblastic leukemia cells targeted with a-fucosylated anti-CD19 humanized antibodies

scientific article

Pyrosequencing for classification of human FcγRIIIA allotypes: a comparison with PCR-based techniques.

scientific article published in December 2014

Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells.

scientific article published in June 2018